HANCE SCARBOROUGH lobbying for ALLIANCE FOR PHARMACY COMPOUNDING

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 17, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Lobbyists on this filing 3

ROBERT DAVID PORE

Previously held: Legislative Director, Cong. Jim Turner
MICHAEL TOMBERLIN

Previously held: Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
THERESA REED

Previously held: Leg. Director for Multiple Members

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Bills named in this filing 1

H.R. 167
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023